药学服务对老年慢性阻塞性肺病患者临床疗效的影响

lmpact on the clinical efficacy of elderly patients with chronic obstructive pulmonary disease pharmacy services

目的：探讨药学服务对老年慢性阻塞性肺病患者临床疗效的影响。方法：对2012年7月到2014年7月我院收治的85例慢性阻塞性肺病患者的临床资料进行回顾性分析，45例患者进行药学服务（观察组），40例患者不进行药学服务（对照组）。记录两组患者入院时和出院时的CAT评分和mMRC分级，比较两组患者的治疗相关情况。结果：观察组入院时CAT评分和mMRC分级分别为27.01±4.74、2.56±0.49，出院时CAT评分和mMRC分级分别为20.07±4.96、2.46±0.51；对照组入院时CAT评分和mMRC分级分别为27.99±3.75、2.76±0.59，出院时CAT评分和mMRC分级分别为24.46±5.27、2.74±0.69；两组患者入院时和出院时CAT评分和mMRC分级比较，入院时组间差异不具有统计学意义（P〉0.05），出院时组间差异具有统计学意义（P＜0.05）。观察组住院时间和治疗费用分别为（13.68±4.27）d、（11274.26±5930.28）y；对照组住院时间和治疗费用分别为（16.53±6.29）d、（14173.49±6293.39）y；两组患者治疗相关情况比较，差异具有统计学意义（P＜0.05）。结论：医院对老年慢性阻塞性肺病患者进行药学服务，对患者的病情有积极作用，能有效提高临床疗效。

Objective： To investigate the impact of pharmaceutical care on clinical efficacy in elderly patients with chronic obstructive pulmonary disease. Methods： The clinical data in July 2012 to July 2014 in our hospital, 85 patients with chronic obstructive pulmonary disease were retrospectively analyzed 45 patients were pharmacy services （study group）, 40 patients without pharmacy services （ the control group）. Two groups of patients admitted to hospital discharge records at the CAT scores and mMRC classification and treatment-related cases between the two groups of patients. Results： The study group admission CAT scores and mMRC grade were 27.01 ± 4.74,2.56 ± 0.49, CAT score at discharge and mMRC grade were 20.07 ± 4.96,2.46 ± 0.51; when the control group on admission CAT scores and grade were 27.99 mMRC ± 3.75,2.76 ± 0.59, CAT score at discharge and mMRC grade were 24.46 ± 5.27,2.74 ± 0.69; when the two groups of patients admitted to hospital CAT scores and mMRC grades of discharge and, between admission groups were not statistically significant （ P〉 0.05）, between discharge group difference was statistically significant （P 〈0.05）. Observation group hospitalization and treatment costs were （13.68 ± 4.27） d, （11274.26 ± 5930.28） y; group hospitalization and treatment costs were （16.53 ± 6.29） d, （14173.49 ± 6293.39） y; two groups of patients the relevant circumstances, the difference was statistically significant （P 〈0.05）. Conclusion： Hospital for elderly patients with chronic obstructive pulmonary disease pharmaceutical care, the patient＇s condition has a positive effect, can effectively improve the clinical efficacy.